South Dakota 2022 Regular Session

South Dakota House Bill HB1086

Introduced
1/20/22  
Refer
1/20/22  
Report Pass
1/27/22  
Engrossed
2/2/22  
Refer
2/3/22  
Report Pass
2/25/22  
Enrolled
2/28/22  

Caption

Provide for the redistribution of donated prescription drugs and medical supplies.

Impact

The legislation amends current state laws by outlining the procedures and responsibilities for pharmacies that wish to take part in the donation program. It includes provisions that prevent donated drugs and medical supplies from being resold or eligible for reimbursement under medical assistance programs, which helps maintain the integrity and intent of the donation process. The creation of an electronic database by the State Board of Pharmacy to track these donations is also a crucial provision of the bill, promising better accountability and transparency for both pharmacies and patients.

Summary

House Bill 1086 is introduced to facilitate the redistribution of donated prescription drugs and medical supplies in South Dakota. It establishes regulations for participating pharmacies regarding the acceptance, inspection, and dispensing of these donated items. Specifically, it mandates that participating pharmacies can accept donations as long as they meet certain criteria, including being in tamper-evident packaging and not having expired. This bill aims to improve access to necessary medications and supplies for underserved populations, particularly the indigent or uninsured.

Sentiment

The general sentiment around HB 1086 is supportive, as it is framed as a compassionate measure aimed at addressing healthcare access disparities in the state. Supporters, including various healthcare advocates, emphasize the potential benefits for those unable to afford necessary medications. However, there may also be some contention regarding the operational aspects such as the logistical challenges and the responsibilities placed on pharmacies, which could lead to concerns about compliance and the provision of care.

Contention

Notable points of contention might arise around the specifics of the eligibility criteria for receiving donated drugs, especially as they prioritize indigent persons. Critics may argue that clearer definitions and processes are needed to ensure equitable access to donated supplies. Pharmacies may have reservations about the liability protections outlined for manufacturers and the responsibility of ensuring the quality and safety of donated drugs, contributing to a complex discussion about the balance between accessibility, safety, and pharmacy operations.

Companion Bills

No companion bills found.

Similar Bills

CA AB2863

Health care coverage: prescriptions.

CA AB852

Health care practitioners: electronic prescriptions.

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025 Applicability date: 07/01/2025

IA HF852

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(Formerly HSB 99.)

IA SSB1074

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See SF 383.)

IA HSB99

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See HF 852.)

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

NM HB132

Mail-order & Community Pharmacy Access